All
My Brain Cancer Journey After Giving Birth
Two months after giving birth to my daughter, I noticed something was unusual, which led to my diagnosis of anaplastic oligodendroglioma.
Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care
An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.
Understanding Multiple Myeloma Symptoms
Reflecting on the pain I experienced before my diagnosis of multiple myeloma, I realized how important it was to pay attention to the related symptoms.
FDA Approves Presurgical, Postsurgical Opdivo for NSCLC
The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.
FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic HER2-low or -ultralow breast cancer.
Perioperative Opdivo Extends Event-Free Survival in Lung Cancer
Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.
Herceptin, Perjeta Regimen May Be Effective Without Chemo in Breast Cancer
Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without chemotherapy.
Gleevec Interruption in GIST Associated with Resistance, Recurrence, Death
Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal stromal tumors.
Cancer Makes Me Look at Life Differently
After recently losing my aunt, I realized that cancer has given me a new perspective on life, which reminds me that every day has meaning.
Hypofractionated Preoperative RT May Be Safe And Effective in Soft Tissue Sarcoma
Patients with soft tissue sarcomas showed improved functional results, quality of life and fewer side effects when treated with RT-therapy.
Longer Time Until Recurrence Associated With Better Melanoma Outcomes
An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved progression and survival.
Long-Term Study Data Support Keytruda as Standard of Care for Advanced Melanoma
Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.
Theranostics a ‘State-of-the-Art’ Treatment Option for Prostate Cancer
For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options.
Bracing for the Impact of Pinktober for Breast Cancer
As a breast cancer survivor, I’ve learned to navigate the annual sea of pink, but I don’t like it.
Oncology Drugs Approved by the FDA in September 2024
Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.
Fotivda Shows Better Outcomes Than Combo in Metastatic Kidney Cancer
Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic kidney cancer.
Anti-PD-L1 Antibody Drug Combo May Improve Outcomes in Advanced Kidney Cancer
Benmelstobart plus anlotinib significantly improved survival versus Sutent in the first-line treatment of advanced renal cell carcinoma.
Celebrating 4 Years Cancer-Free
I invited my family to gather with me and celebrate four years of being cancer-free.
NBA Star Dikembe Mutombo Dies of Brain Cancer
The Hall of Famer has died from brain cancer at the age of 58, the NBA has announced.
Chemo Shortage Increases Treatment Costs by 16% for Head and Neck Cancer
In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the cisplatin shortage.
Lower Keytruda Doses May Be as Effective as Standard Doses for Stage 4 NSCLC
Patients with stage 4 non-small cell lung cancer may derive an equal benefit with a lower dose of Keytruda versus the standard dose.
Side Effects, Quality of Life Important to Consider in Breast Cancer Subset
Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments.
Guiding Hope for Patients With Lung Cancer
Two colleagues of Amy Wallace, an oncology nurse, nominated her for the Extraordinary Healer Award based on her care of patients with lung cancer.
Path to Previvor: My Journey from Diagnosis to Advocacy
My path as a previvor is far from being straightforward, but having available resources and support has helped me along the way.
FDA Approves Retevmo for Some With Medullary Thyroid Cancer
The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer.
Prostate Cancer Questions Answered on Surgery, Side Effects and More
An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.
There is Nothing Pink About Breast Cancer
As a caregiver to my daughter who had breast cancer, pink takes on a new meaning for us — one I’m not quite a fan of.
Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More
From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.
Supplemental New Drug Application Submitted for Nubeqa in Prostate Cancer Subset
The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
Cediranib Added to Lynparza Didn’t Improve Progression, Survival in Ovarian Cancer
A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.
